Precigen Ownership | Who Owns Precigen?
Precigen Ownership Summary
Precigen is owned by 24.38% institutional investors, 10.17% insiders, and 65.45% retail investors. Patient capital management is the largest institutional shareholder, holding 7.29% of PGEN shares. Patient Opportunity C is the top mutual fund, with 4.92% of its assets in Precigen shares.
PGEN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Precigen | 24.38% | 10.17% | 65.45% |
Sector | Healthcare Stocks | 47.25% | 8.01% | 44.75% |
Industry | Biotech Stocks | 45.35% | 7.81% | 46.83% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Patient Opportunity C | 14.40M | 4.92% | -99.79K |
Vanguard Total Stock Mkt Idx Inv | 5.45M | 1.86% | - |
iShares Russell 2000 ETF | 3.36M | 1.15% | -7.56K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.91M | 0.65% | - |
Fidelity Small Cap Index | 1.31M | 0.45% | -13.38K |
iShares Russell 2000 Value ETF | 1.09M | 0.37% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 914.71K | 0.31% | -26.00K |
Fidelity Extended Market Index | 864.49K | 0.30% | 104.70K |
iShares Biotechnology ETF | 820.97K | 0.28% | -4.91K |
JPM Thematics Genetic Thrps C2 Acc USD | 777.30K | 0.27% | -23.26K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 09, 2024 | Perez Jeffrey Thomas | SVP, IP Affairs | Buy | $50.00K |
Aug 09, 2024 | KIRK RANDAL J | Buy | $20.00M | |
Dec 28, 2023 | KIRK RANDAL J | Buy | $136.33K | |
Dec 28, 2023 | KINDLER JEFFREY B | - | Sell | $136.33K |
Sep 22, 2023 | MITCHELL DEAN J | - | Buy | $35.25K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | 1 | 1 |
2023 Q3 | 7 | 20 |
PGEN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools